ARTG 426430Clarity II & Clarity II LPA - Dermatological Nd:YAG laser system
ARTG ID: 426430 · Ebos Medical Devices Australia Pty Ltd · Lutronic Corporation · Class IIb · Started October 20, 2023
Good Name: Ebos Medical Devices Australia Pty Ltd - Clarity II & Clarity II LPA - Dermatological Nd:YAG laser system
- Risk Class
- Class IIb
- Product Type
- Medical device system
- ARTG Category
- General
- ARTG ID
- 426430
- Start Date
- October 20, 2023
- Effective Date
- October 20, 2023
- Country
- South Korea
- Address
- Lutronic Center 219 Sowon-ro Deogyang-gu, Goyang-si, Gyeonggi-do
The ND:YAG(1064nm) wavelength of Clarity II is intended for use in the treatment to reduce the papule of Pseudofollicular barbae and to improve the port wine stain. The Alexandrite(755nm) wavelength of Clarity II and Clarity II LPA is intended for use in the treatment to reduce the papule of Pseudofollicular barbae, to improve the port wine stain and to remove the congenical melancytic Nevus.
Access comprehensive regulatory information for Clarity II & Clarity II LPA - Dermatological Nd:YAG laser system in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is registered under ARTG number 426430 and sponsored by Ebos Medical Devices Australia Pty Ltd, manufactured by Lutronic Corporation in South Korea. The device registration started on October 20, 2023.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.